Evidence map›Paper›PMID 35287587›Full record

ArticleBMC immunology2022

Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1.

Raquel Matavele Chissumba, Cacildo Magul, Rosa Macamo, Vânia Monteiro, Maria Enosse, Ivalda Macicame, Victória Cumbane, Nilesh Bhatt, Edna Viegas, Michelle Imbach and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Raquel Matavele ChissumbaInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique. raquel.matavele@ins.gov.mz.
Cacildo MagulInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Rosa MacamoInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Vânia MonteiroInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Maria EnosseInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Ivalda MacicameInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Victória CumbaneInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Nilesh BhattInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Edna ViegasInstituto Nacional de Saúde, Distrito de Marracuene, Estrada Nacional N°1, Marracuene, Província de Maputo, Mozambique.
Michelle ImbachU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Leigh Anne EllerU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Christina S PolyakU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Luc KestensInstitute of Tropical Medicine, Department of Biomedical Sciences, Antwerp, Belgium.
RV363 Study Group
Instituto Nacional de Saúde · MZHenry M. Jackson Foundation · USUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus type 1 (HIV-1) causes impairment of T and B cell responses, which begins during the acute phase of infection and is not completely restored by antiretroviral treatment. Regulatory T cell (Tregs) can improve overall disease outcome by controlling chronic inflammation but may also suppress beneficial HIV-1 specific immune responses. We aimed to analyze the profile of Tregs and their correlation with the status of T cells activation, the expression of IL-2 and IFNγ and the profile of HIV-1 specific antibodies response in Mozambican people living chronically with HIV-1 (PLWH-C).

resultsIn PLWH-C, the proportion of total Tregs was positively correlated with the proportion of IL-2

conclusionAmong Mozambican people living with HIV-1, seronegativity to some HIV-1 proteins is common, particularly in virologically suppressed individuals. Furthermore, lower diversity of HIV-specific antibodies is correlated to lower immune activation, lower viral replication and higher CD4 counts, in PLWH-C. Elevation in the proportion of Helios

Indexed as

HIV-1HIV InfectionsAntibody DiversityCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansInterleukin-2Lymphocyte ActivationMozambiqueT-Lymphocytes, RegulatoryInterleukin-2HeliosHIV chronic infectionSeronegativityTregs

Identifiers

PMID35287587
PMCPMC8922818
OpenAlexW4220658749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.